On Fortification of Projection Games

A recent result of Moshkovitz \cite{Moshkovitz14} presented an ingenious method to provide a completely elementary proof of the Parallel Repetition Theorem for certain projection games via a construction called fortification. However, the construction used in \cite{Moshkovitz14} to fortify arbitrary label cover instances using an arbitrary extractor is insufficient to prove parallel repetition. In this paper, we provide a fix by using a stronger graph that we call fortifiers. Fortifiers are graphs that have both $\ell_1$ and $\ell_2$ guarantees on induced distributions from large subsets. We then show that an expander with sufficient spectral gap, or a bi-regular extractor with stronger parameters (the latter is also the construction used in an independent update \cite{Moshkovitz15} of \cite{Moshkovitz14} with an alternate argument), is a good fortifier. We also show that using a fortifier (in particular $\ell_2$ guarantees) is necessary for obtaining the robustness required for fortification.Comment: 19 page

Guruswami-Sinop Rounding without Higher Level Lasserre

Guruswami and Sinop give a O(1/delta) approximation guarantee for the non-uniform Sparsest Cut problem by solving O(r)-level Lasserre semidefinite constraints, provided that the generalized eigenvalues of the Laplacians of the cost and demand graphs satisfy a certain spectral condition, namely, the (r+1)-th generalized eigenvalue is at least OPT/(1-delta). Their key idea is a rounding technique that first maps a vector-valued solution to [0,1] using appropriately scaled projections onto Lasserre vectors. In this paper, we show that similar projections and analysis can be obtained using only l_2^2 triangle inequality constraints. This results in a O(r/delta^2) approximation guarantee for the non-uniform Sparsest Cut problem by adding only l_2^2 triangle inequality constraints to the usual semidefinite program, provided that the same spectral condition, the (r+1)-th generalized eigenvalue is at least OPT/(1-delta), holds

Approximating Sparsest Cut in Low Rank Graphs via Embeddings from Approximately Low Dimensional Spaces

We consider the problem of embedding a finite set of points x_1, ...x_n in R^d that satisfy l_2^2 triangle inequalities into l_1, when the points are approximately low-dimensional. Goemans (unpublished, appears in a work of Magen and Moharammi (2008) ) showed that such points residing in exactly d dimensions can be embedded into l_1 with distortion at most sqrt{d}. We prove the following robust analogue of this statement: if there exists a r-dimensional subspace Pi such that the projections onto this subspace satisfy sum_{i,j in [n]} norm{Pi x_i - Pi x_j}_2^2 >= Omega(1) * sum_{i,j in [n]} norm{x_i - x_j}_2^2, then there is an embedding of the points into l_1 with O(sqrt{r}) average distortion. A consequence of this result is that the integrality gap of the well-known Goemans-Linial SDP relaxation for the Uniform Sparsest Cut problem is O(sqrt{r}) on graphs G whose r-th smallest normalized eigenvalue of the Laplacian satisfies lambda_r(G)/n >= Omega(1)*Phi_{SDP}(G). Our result improves upon the previously known bound of O(r) on the average distortion, and the integrality gap of the Goemans-Linial SDP under the same preconditions, proven in [Deshpande and Venkat, 2014], and [Deshpande, Harsha and Venkat 2016]

Semi-random Graphs with Planted Sparse Vertex Cuts: Algorithms for Exact and Approximate Recovery

The problem of computing the vertex expansion of a graph is an NP-hard problem. The current best worst-case approximation guarantees for computing the vertex expansion of a graph are a O(sqrt{log n})-approximation algorithm due to Feige et al. [Uriel Feige et al., 2008], and O(sqrt{OPT log d}) bound in graphs having vertex degrees at most d due to Louis et al. [Louis et al., 2013]. We study a natural semi-random model of graphs with sparse vertex cuts. For certain ranges of parameters, we give an algorithm to recover the planted sparse vertex cut exactly. For a larger range of parameters, we give a constant factor bi-criteria approximation algorithm to compute the graph\u27s balanced vertex expansion. Our algorithms are based on studying a semidefinite programming relaxation for the balanced vertex expansion of the graph. In addition to being a family of instances that will help us to better understand the complexity of the computation of vertex expansion, our model can also be used in the study of community detection where only a few nodes from each community interact with nodes from other communities. There has been a lot of work on studying random and semi-random graphs with planted sparse edge cuts. To the best of our knowledge, our model of semi-random graphs with planted sparse vertex cuts has not been studied before

Embedding Approximately Low-Dimensional l_2^2 Metrics into l_1

Goemans showed that any n points x_1,..., x_n in d-dimensions satisfying l_2^2 triangle inequalities can be embedded into l_{1}, with worst-case distortion at most sqrt{d}. We consider an extension of this theorem to the case when the points are approximately low-dimensional as opposed to exactly low-dimensional, and prove the following analogous theorem, albeit with average distortion guarantees: There exists an l_{2}^{2}-to-l_{1} embedding with average distortion at most the stable rank, sr(M), of the matrix M consisting of columns {x_i-x_j}_{i<j}. Average distortion embedding suffices for applications such as the SPARSEST CUT problem. Our embedding gives an approximation algorithm for the SPARSEST CUT problem on low threshold-rank graphs, where earlier work was inspired by Lasserre SDP hierarchy, and improves on a previous result of the first and third author [Deshpande and Venkat, in Proc. 17th APPROX, 2014]. Our ideas give a new perspective on l_{2}^{2} metric, an alternate proof of Goemans\u27 theorem, and a simpler proof for average distortion sqrt{d}

Multiplayer Parallel Repetition for Expanding Games

We investigate the value of parallel repetition of one-round games with any number of players k>=2. It has been an open question whether an analogue of Raz\u27s Parallel Repetition Theorem holds for games with more than two players, i.e., whether the value of the repeated game decays exponentially with the number of repetitions. Verbitsky has shown, via a reduction to the density Hales-Jewett theorem, that the value of the repeated game must approach zero, as the number of repetitions increases. However, the rate of decay obtained in this way is extremely slow, and it is an open question whether the true rate is exponential as is the case for all two-player games. Exponential decay bounds are known for several special cases of multi-player games, e.g., free games and anchored games. In this work, we identify a certain expansion property of the base game and show all games with this property satisfy an exponential decay parallel repetition bound. Free games and anchored games satisfy this expansion property, and thus our parallel repetition theorem reproduces all earlier exponential-decay bounds for multiplayer games. More generally, our parallel repetition bound applies to all multiplayer games that are *connected* in a certain sense. We also describe a very simple game, called the GHZ game, that does not satisfy this connectivity property, and for which we do not know an exponential decay bound. We suspect that progress on bounding the value of this the parallel repetition of the GHZ game will lead to further progress on the general question

Rationale and protocol for estimating the economic value of a multicomponent quality improvement strategy for diabetes care in South Asia.

BACKGROUND: Economic dimensions of implementing quality improvement for diabetes care are understudied worldwide. We describe the economic evaluation protocol within a randomised controlled trial that tested a multi-component quality improvement (QI) strategy for individuals with poorly-controlled type 2 diabetes in South Asia. METHODS/DESIGN: This economic evaluation of the Centre for Cardiometabolic Risk Reduction in South Asia (CARRS) randomised trial involved 1146 people with poorly-controlled type 2 diabetes receiving care at 10 diverse diabetes clinics across India and Pakistan. The economic evaluation comprises both a within-trial cost-effectiveness analysis (mean 2.5 years follow up) and a microsimulation model-based cost-utility analysis (life-time horizon). Effectiveness measures include multiple risk factor control (achieving HbA1c < 7% and blood pressure < 130/80 mmHg and/or LDL-cholesterol< 100 mg/dl), and patient reported outcomes including quality adjusted life years (QALYs) measured by EQ-5D-3 L, hospitalizations, and diabetes related complications at the trial end. Cost measures include direct medical and non-medical costs relevant to outpatient care (consultation fee, medicines, laboratory tests, supplies, food, and escort/accompanying person costs, transport) and inpatient care (hospitalization, transport, and accompanying person costs) of the intervention compared to usual diabetes care. Patient, healthcare system, and societal perspectives will be applied for costing. Both cost and health effects will be discounted at 3% per year for within trial cost-effectiveness analysis over 2.5 years and decision modelling analysis over a lifetime horizon. Outcomes will be reported as the incremental cost-effectiveness ratios (ICER) to achieve multiple risk factor control, avoid diabetes-related complications, or QALYs gained against varying levels of willingness to pay threshold values. Sensitivity analyses will be performed to assess uncertainties around ICER estimates by varying costs (95% CIs) across public vs. private settings and using conservative estimates of effect size (95% CIs) for multiple risk factor control. Costs will be reported in US$ 2018. DISCUSSION: We hypothesize that the additional upfront costs of delivering the intervention will be counterbalanced by improvements in clinical outcomes and patient-reported outcomes, thereby rendering this multi-component QI intervention cost-effective in resource constrained South Asian settings. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01212328

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

Background: A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97\ub71 (95% UI 95\ub78-98\ub71) in Iceland, followed by 96\ub76 (94\ub79-97\ub79) in Norway and 96\ub71 (94\ub75-97\ub73) in the Netherlands, to values as low as 18\ub76 (13\ub71-24\ub74) in the Central African Republic, 19\ub70 (14\ub73-23\ub77) in Somalia, and 23\ub74 (20\ub72-26\ub78) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91\ub75 (89\ub71-93\ub76) in Beijing to 48\ub70 (43\ub74-53\ub72) in Tibet (a 43\ub75-point difference), while India saw a 30\ub78-point disparity, from 64\ub78 (59\ub76-68\ub78) in Goa to 34\ub70 (30\ub73-38\ub71) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4\ub78-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20\ub79-point to 17\ub70-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17\ub72-point to 20\ub74-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view-and subsequent provision-of quality health care for all populations

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

Copyright © 2018 The Author(s). Published by Elsevier Ltd. Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8-98·1) in Iceland, followed by 96·6 (94·9-97·9) in Norway and 96·1 (94·5-97·3) in the Netherlands, to values as low as 18·6 (13·1-24·4) in the Central African Republic, 19·0 (14·3-23·7) in Somalia, and 23·4 (20·2-26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91·5 (89·1-93·6) in Beijing to 48·0 (43·4-53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point disparity, from 64·8 (59·6-68·8) in Goa to 34·0 (30·3-38·1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view - and subsequent provision - of quality health care for all populations